Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer

NCT03936218 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Prostate Cancer

Interventions

DRUG: Inj. Goserelin (Test) Subcutaneously
DRUG: Inj. Zoladex (Reference) Subcutaneously

Sponsor

Eurofarma Laboratorios S.A.